ArticleFrontiers in pharmacology2021

SH-1028, An Irreversible Third-Generation EGFR TKI, Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer.

Luwei Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.